The Experts below are selected from a list of 82587 Experts worldwide ranked by ideXlab platform
Shintaro Beppu - One of the best experts on this subject based on the ideXlab platform.
-
gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume <83.7 ml. In the multivariate analysis, gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041). Conclusions Pretreatment gross Tumor Volume of primary Tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.
-
Gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume
Hidenori Suzuki - One of the best experts on this subject based on the ideXlab platform.
-
gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume <83.7 ml. In the multivariate analysis, gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041). Conclusions Pretreatment gross Tumor Volume of primary Tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.
-
Gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume
Daisuke Nishikawa - One of the best experts on this subject based on the ideXlab platform.
-
gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume <83.7 ml. In the multivariate analysis, gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041). Conclusions Pretreatment gross Tumor Volume of primary Tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.
-
Gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume
Hiroshi Tanaka - One of the best experts on this subject based on the ideXlab platform.
-
gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume <83.7 ml. In the multivariate analysis, gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041). Conclusions Pretreatment gross Tumor Volume of primary Tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.
-
Gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume
Yutaro Koide - One of the best experts on this subject based on the ideXlab platform.
-
gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume <83.7 ml. In the multivariate analysis, gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041). Conclusions Pretreatment gross Tumor Volume of primary Tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.
-
Gross Tumor Volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.
Japanese Journal of Clinical Oncology, 2018Co-Authors: Hidenori Suzuki, Kana Kimura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Yutaro Koide, Hiroshi Tanaka, Daisuke Nishikawa, Yusuke Koide, Shintaro BeppuAbstract:Objective This study investigated whether gross Tumor Volume of the primary Tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy. Methods A total of 24 patients were enrolled. Pretreatment gross Tumor Volume of primary Tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross Tumor Volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively. Results In the univariate analysis, patients with the gross Tumor Volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross Tumor Volume
